Effect of Glucagon-Like Peptide-1 Receptor Agonists on Bowel Preparation for Colonoscopy
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Inadequate bowel preparation can result in decreased diagnostic accuracy and therapeutic safety of colonoscopy for colon cancer screening. The Boston Bowel Preparation Scale (BBPS) has been used to assess the quality of bowel preparation. Glucagon-like peptide-1 receptor agonists (GLP-1RA) are commonly used medications for diabetes mellitus and obesity that are known to delay gastrointestinal motility. We hypothesized that the use of GLP-1RA would be associated with decreased quality of bowel preparation. METHODS: We performed a retrospective cohort study of patients who underwent screening or surveillance colonoscopy at a large academic medical center between December 2021 and December 2022. We included patients taking any GLP-1RA for diabetes or obesity during colonoscopy defined as our cases, and patients who were prescribed GLP-1RA at one point but not within 3 months of colonoscopy defined as our controls. We excluded patients on any promotility or antimotility agents and those without BBPS recorded on their procedure report. Independent t test assessed statistical differences in the case and control groups to compare the quality of bowel preparation for continuous variables, and the χ 2 test was used for categorical variables. Multivariate linear regression including diabetes as a covariate was also performed for continuous variables, and multivariate logistic regression was performed for categorical variables. RESULTS: A total of 446 patients were included in the study, comprising 265 (59%) cases and 181 controls (41%). There were no statistically significant differences between groups at baseline except for the diagnosis of diabetes (P = 0.001) with a higher proportion of patients with diabetes in the cases. The mean BBPS was significantly higher in controls (7.0 ± 1.9 vs 7.5 ± 2.4, P = 0.046) when controlling for diabetes. The percentage of patients with a total BBPS score of <5 was significantly higher in cases (15.5% vs 6.6%, P = 0.01). The proportion of patients who required a repeat colonoscopy due to poor bowel preparation was also significantly higher in cases (18.9% vs 11.1%, P = 0.041). DISCUSSION: The use of GLP-1RA was associated with a statistically significantly lower quality of bowel preparation, with additional clinical significance given a notable difference in the need for a repeat colonoscopy. It will be essential to understand the cumulative effect of medications that may delay gastric emptying on the quality of bowel preparation to better understand the appropriate measures and counseling that need to be taken before undergoing outpatient colonoscopies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death
Bretthauer, M., Løberg, M., Wieszczy, P., Kalager, M., Emilsson, L., Garborg, K., Rupinski, M., Dekker, E., Spaander, M., Bugajski, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2208375 · Cited by 817
Research works printed but not linked: 11
- Harewood, 2003, Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia, Gastrointest Endosc, 58, 76, 10.1067/mge.2003.294 · DOI · Paper page
- Govani, 2016, Predictors of suboptimal bowel preparation in asymptomatic patients undergoing average-risk screening colonoscopy, World J Gastrointest Endosc, 8, 616, 10.4253/wjge.v8.i17.616 · doi:10.4253/wjge.v8.i17.616
- Mahmood, 2018, Predictors of inadequate bowel preparation for colonoscopy: A systematic review and meta-analysis, Eur J Gastroenterol Hepatol, 30, 819, 10.1097/MEG.0000000000001175 · DOI · Paper page
- Halim, 2018, Glucagon-Like peptide-1 inhibits prandial gastrointestinal motility through myenteric neuronal mechanisms in humans, J Clin Endocrinol Metab, 103, 575, 10.1210/jc.2017-02006 · DOI · Paper page
- Lai, 2009, The Boston bowel preparation scale: A valid and reliable instrument for colonoscopy-oriented research, Gastrointest Endosc, 69, 620, 10.1016/j.gie.2008.05.057 · DOI · Paper page
- Tong, 2023, Impact of glucagon-like peptide 1 receptor agonist liraglutide and dipeptidyl peptidase-4 inhibitor sitagliptin on bowel cleaning and gastrointestinal symptoms in type 2 diabetes, Front Pharmacol, 14, 1176206, 10.3389/fphar.2023.1176206 · DOI
- Sharma, 2017, Evaluation of the effect of GLP-1 agonists on quality of bowel preparation for colonoscopy in patients with diabetes, Pract Diabetes, 34, 167, 10.1002/pdi.2110 · DOI
- Yadlapati, 2015, Predictors of inadequate inpatient colonoscopy preparation and its association with hospital length of stay and costs, Dig Dis Sci, 60, 3482, 10.1007/s10620-015-3761-2 · DOI
- Nguyen, 2010, Risk factors predictive of poor quality preparation during average risk colonoscopy screening: The importance of health literacy, J Gastrointestin Liver Dis, 19, 369
- Clark, 2016, Quantification of adequate bowel preparation for screening or surveillance colonoscopy in men, Gastroenterology, 150, 396, 10.1053/j.gastro.2015.09.041 · DOI · Paper page
- Chirila, 2022, Preparing for colonoscopy in people with diabetes: A review with suggestions for clinical practice, J Can Assoc Gastroenterol, 6, 26, 10.1093/jcag/gwac035 · DOI
Cited by
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
Drucker, D. J. (2024) · Diabetes Care · doi:10.2337/dci24-0003 · Cited by 383
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
Jalleh, R. J., Rayner, C. K., Hausken, T., Jones, K. L., Camilleri, M., & Horowitz, M. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00188-2 · Cited by 144
Ghusn, W., & Hurtado, M. D. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100127 · Cited by 122
Self-citationJalleh, R. J., Marathe, C. S., Rayner, C. K., Jones, K. L., Umapathysivam, M. M., Wu, T., Quast, D. R., Plummer, M. P., Nauck, M. A., & Horowitz, M. (2024) · Endocrinology · doi:10.1210/endocr/bqae155 · Cited by 61
Singh, S., Rahman, S. H., Khan, N., Rajagopal, A., Shafique, N., Tawde, P., Bhardwaj, V., Suresh Kumar, V. C., Aswath, G., Inamdar, S., et al. (2025) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2024.10.011 · Cited by 35
Metadata
- Authors
- Yao, R., Gala, K. S., Ghusn, W., Abboud, D. M., Wallace, F. K., & Vargas, E. J.
- Venue
- American Journal of Gastroenterology
- Published
- 2023-10-19
- Volume
- 119
- Issue
- 6
- Pages
- 1154-1157
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W4387781876
- Cited by
- 52
- References
- 1
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Glucagon-Like Peptide-1 Receptor Agonists on Bowel Preparation for Colonoscopy. https://app.cochat.ai/papers/10.14309/ajg.0000000000002564
- The paper
- Yao, R., Gala, K. S., Ghusn, W., Abboud, D. M., Wallace, F. K., & Vargas, E. J. (2024). Effect of Glucagon-Like Peptide-1 Receptor Agonists on Bowel Preparation for Colonoscopy. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000002564
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.